Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report

BACKGROUND: Rituximab is a well-established component of treatment regimens for B-cell non-Hodgkin lymphoma. Rituximab binds the CD20 antigen on the surface of B lymphocytes, causing an enhanced clearance of malignant and benign B cells. Thus, rituximab leads to depletion of normal B lymphocytes as...

Descripción completa

Detalles Bibliográficos
Autores principales: Higer, Maximilian, Cana, Denis, Podlech, Juergen, Schadmand-Fischer, Simin, Schwarting, Andreas, Teschner, Daniel, Theobald, Matthias, Wölfel, Thomas, Hess, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456041/
https://www.ncbi.nlm.nih.gov/pubmed/32859260
http://dx.doi.org/10.1186/s13256-020-02457-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456041/
https://www.ncbi.nlm.nih.gov/pubmed/32859260
http://dx.doi.org/10.1186/s13256-020-02457-y

Ejemplares similares